N. Bossard

发表

Estimating net survival: the importance of allowing for informative censoring

Laurent Remontet, Aurélien Belot, Nadine Bossard, 2012, Statistics in medicine.

Survival of solid cancer patients in France, 1989–2013: a population-based study

N. Voirin, A. Guizard, B. Trétarre, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy.

R. Écochard, P. Maingon, P. Romestaing, 2013, International journal of radiation oncology, biology, physics.

Trends in net survival from 15 cancers in six European Latin countries: the SUDCAN population-based study material

J. Faivre, R. Capocaccia, E. Crocetti, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Performance of two formal tests based on martingales residuals to check the proportional hazard assumption and the functional form of the prognostic factors in flexible parametric excess hazard models

Coraline Danieli, L. Remontet, N. Bossard, 2017, Biostatistics.

Framework and optimisation procedure for flexible parametric survival models

J. Estève, L. Remontet, N. Bossard, 2015, Statistics in medicine.

Trends in probabilities of death owing to cancer and owing to other causes in patients with colon cancer

V. Jooste, A. Bouvier, L. Remontet, 2019, European journal of gastroenterology & hepatology.

Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries.

R. Malekzadeh, Y. Teo, M. Coleman, 2022, The Lancet. Child & adolescent health.

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Melissa Matz, F Berrino, B Rachet, 2018, The Lancet.

Socioeconomic environment and disparities in cancer survival for 19 solid tumor sites: An analysis of the French Network of Cancer Registries (FRANCIM) data

G. Launoy, L. Tron, O. Dejardin, 2018, International journal of cancer.

[Diversity of incidence trend patterns: implications for carcinogenesis?].

R. Écochard, G. Launoy, L. Remontet, 2011, Revue des maladies respiratoires.

Registry of multicenter clinical trials: 14th and 15th report 1992-1993.

J. Boissel, N. Bossard, 1996, Controlled clinical trials.

Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).

R. De Angelis, X. Troussard, M. Sant, 2015, The Lancet. Haematology.

Trends in incidence of digestive cancers in France

G. Launoy, C. Lepage, J. Faivre, 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Breast cancer incidence using administrative data: correction with sensitivity and specificity.

A. Schott, L. Remontet, M. Colonna, 2009, Journal of clinical epidemiology.

Is it possible to estimate the incidence of breast cancer from medico-administrative databases?

A. Schott, L. Remontet, M. Colonna, 2008, European Journal of Epidemiology.

Unbiased estimates of long‐term net survival of solid cancers in France

G. Launoy, V. Jooste, P. Arveux, 2013, International journal of cancer.

A new approach to estimate time-to-cure from cancer registries data.

V. Jooste, A. Bouvier, C. Binquet, 2018, Cancer epidemiology.

Conditional relative survival of cancer patients and conditional probability of death

G. Hédelin, G. Launoy, V. Jooste, 2009, Cancer.

Trends in net survival from rectal cancer in six European Latin countries: results from the SUDCAN population-based study

C. Lepage, J. Faivre, O. Dejardin, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial.

P. Romestaing, J. Gérard, F. Mornex, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980-2005 and projection to 2010.

G. Launoy, A. Guizard, C. Righini, 2011, Oral Oncology.

Prognostic factors and long-term results of pulmonary metastasectomy for pediatric histologies.

L. Remontet, N. Bossard, J. Gamondès, 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

National cancer incidence is estimated using the incidence/mortality ratio in countries with local incidence data: is this estimation correct?

P. Grosclaude, L. Remontet, M. Colonna, 2013, Cancer epidemiology.

Joint use of epidemiological and hospital medico-administrative data to estimate prevalence. Application to French data on breast cancer.

A. Schott, L. Remontet, M. Colonna, 2012, Cancer epidemiology.

Thyroid cancer: is the incidence rise abating?

G. Sassolas, F. Borson‐Chazot, J. Orgiazzi, 2009, European journal of endocrinology.

Trends in net survival from liver cancer in six European Latin countries: results from the SUDCAN population-based study

A. Bordoni, J. Faivre, S. Ferretti, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.

L. Remontet, N. Bossard, A. Belot, 2013, Cancer epidemiology.

Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival.

A. Guizard, P. Grosclaude, L. Remontet, 2010, Annales d'endocrinologie.

Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France

A. Guizard, F. Virard, N. Bossard, 2021, International journal of cancer.

Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).

G. Launoy, J. Faivre, P. Arveux, 2007, European journal of cancer.

New insights into survival trend analyses in cancer population-based studies: the SUDCAN methodology

L. Remontet, N. Bossard, L. Roche, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population study.

C. Preudhomme, T. Facon, L. Remontet, 2011, Blood.

Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.

P. Arveux, A. Guizard, B. Trétarre, 2015, Gynecologic oncology.

Changes in the risk of death from cancer up to five years after diagnosis in elderly patients: A study of five common cancers

P. Grosclaude, L. Remontet, M. Colonna, 2010, International journal of cancer.

[Critical analysis of French DRG based information system (PMSI) databases for the epidemiology of cancer: a longitudinal approach becomes possible].

A. Schott, L. Remontet, M. Colonna, 2011, Revue d'epidemiologie et de sante publique.

[Prognostic importance of ambulatory arterial pressure monitoring in France. Initial results of the OCTAVE II study. OCTAVE II Research Group].

F. Gueyffier, J. Boissel, G. Jullien, 1999, Archives des maladies du coeur et des vaisseaux.

Type of day-care setting and risk of repeated infections.

J. Collet, T. Ducruet, N. Bossard, 1994, Pediatrics.

Cytoreductive Surgery With Intraperitoneal Chemohyperthermia for the Treatment of Pseudomyxoma Peritonei: A Prospective Study

C. Brigand, S. Causeret, F. Gilly, 2005, Diseases of the colon and rectum.

[Hierarchies according to the level of evidence of source data, before their integration in the synthesis, in the matter of therapeutic efficacy].

J. Boissel, N. Bossard, G. Duru, 1996, Therapie.

Drug prescription in young children: results of a survey in France

J. Collet, J. Boissel, N. Bossard, 2004, European Journal of Clinical Pharmacology.

Level of evidence and therapeutic evaluation: need for more thoughts

Nadine Bossard, Jean-Pierre Boissel, François-Henri Boissel, 2004, Fundamental & clinical pharmacology.

Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism.

F. Borson‐Chazot, P. Gaucherand, J. Orgiazzi, 2014, European journal of endocrinology.

Mediolateral oversizing influences pain, function, and flexion after TKA

M. Bonnin, N. Bossard, E. Dantony, 2013, Knee Surgery, Sports Traumatology, Arthroscopy.

An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies

J. Estève, L. Remontet, L Remontet, 2007, Statistics in medicine.

Increased incidence of femoral fractures in small femurs and women undergoing uncemented total hip arthroplasty - why?

M. Bonnin, C. Murphy, N. Bossard, 2015, The bone & joint journal.

No effect of a homoeopathic combination of Arnica montana and Bryonia alba on bleeding, inflammation, and ischaemia after aortic valve surgery.

A. Bissery, J. Lehot, C. Bauer, 2010, British journal of clinical pharmacology.

Cancer incidence and mortality in France over the 1980-2012 period: solid tumors.

L. Remontet, L Remontet, N Bossard, 2014, Revue d'epidemiologie et de sante publique.

[Prostate cancer incidence and mortality trends in France from 1980 to 2011].

P. Grosclaude, L. Remontet, M. Velten, 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

The histology of brain tumours for 67,331 children and 671,085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3).

R. Malekzadeh, M. Coleman, S. Rosso, 2021, Neuro-oncology.

Cancer incidence and mortality in France over the period 1980-2005.

M Colonna, N. Le Stang, G. Hédelin, 2008, Revue d'epidemiologie et de sante publique.

Oversizing the tibial component in TKAs: incidence, consequences and risk factors

M. Bonnin, N. Bossard, E. Dantony, 2016, Knee Surgery, Sports Traumatology, Arthroscopy.

Flexible and structured survival model for a simultaneous estimation of non-linear and non-proportional effects and complex interactions between continuous variables: Performance of this multidimensional penalized spline approach in net survival trend analysis

Laurent Remontet, Jean Iwaz, Zoé Uhry, 2018, Statistical methods in medical research.

Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005

N. Le Stang, F. Galateau-Sallé, M. Goldberg, 2010, International journal of cancer.

Keeping Data Continuous when Analyzing the Prognostic Impact of a Tumor Marker: An Example with Cathepsin D in Breast Cancer

J. Estève, A. Awada, F. Golfier, 2003, Breast Cancer Research and Treatment.

Total and partial cancer prevalence in the adult French population in 2008

P. Grosclaude, M. Colonna, N. Bossard, 2015, BMC Cancer.

Trends in excess mortality in follicular lymphoma at a population level

R. Giorgi, L. Remontet, R. Casasnovas, 2015, European journal of haematology.

Cancer incidence and mortality trends in France over 1990–2018 for solid tumors: the sex gap is narrowing

G. Defossez, V. Bouvier, A. Guizard, 2021, BMC Cancer.

Cancer incidence and mortality in France over the 1980-2012 period: Solid tumors Incidence et mortalitedes cancers en France durant la periode 1980-2012 : tumeurs solides

L. Remontet, N. Bossard, A. Belot, 2015 .

Cancer net survival on registry data: Use of the new unbiased Pohar‐Perme estimator and magnitude of the bias with the classical methods

Coraline Danieli, P. Grosclaude, A. Bouvier, 2013, International journal of cancer.

Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial.

N. Girard, B. Milleron, J. Douillard, 2010, Lung cancer.

Risk of infectious diseases in children attending different types of day-care setting. Epicrèche Research Group.

J. Collet, T. Ducruet, N. Bossard, 1994, Respiration; international review of thoracic diseases.

Trends in net survival from pancreatic cancer in six European Latin countries: results from the SUDCAN population-based study

M. Carulla, A. Bouvier, M. Colonna, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Diagnosed with Cancer in Mainland France 1989-2018 Summary of Results: Solid Tumours and Haematological Malignancies

G. Defossez, B. Trétarre, P. Grosclaude, 2021 .

Incidence trends for potentially human papillomavirus‐related and ‐unrelated head and neck cancers in France using population‐based cancer registries data: 1980–2012

G. Launoy, A. Guizard, N. Bossard, 2017, International journal of cancer.

Breastfeeding and risk of breast cancer: a metaanalysis of published studies.

J. Thalabard, M. Bernier, N. Bossard, 2000, Human reproduction update.

Cancer incidence in France over the 1980-2012 period: Hematological malignancies.

X. Troussard, L. Remontet, A. Monnereau, 2016, Revue d'epidemiologie et de sante publique.

Registry of multicenter clinical trials. Eleventh report--1989.

J. Boissel, N. Bossard, 1991, Thrombosis and haemostasis.

Subcommittee on Clinical Trials: Registry of Multicenter Clinical Trials

J. Boissel, N. Bossard, 1991, Thrombosis and Haemostasis.

Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol.

C. Alberti, L. Remontet, B. Kassai, 2021, Therapie.

A multilevel excess hazard model to estimate net survival on hierarchical data allowing for non‐linear and non‐proportional effects of covariates

Bernard Rachet, Laurent Remontet, Aurélien Belot, 2016, Statistics in medicine.

Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.

N. Girard, M. Ychou, M. Ducreux, 2006, International journal of radiation oncology, biology, physics.

Analysis of the effect of age on the prognosis of breast cancer

E. Sellier, L. Remontet, M. Colonna, 2009, Breast Cancer Research and Treatment.

Cancer incidence estimation at a district level without a national registry: a validation study for 24 cancer sites using French health insurance and registry data.

A. Weill, P. Grosclaude, L. Remontet, 2013, Cancer epidemiology.

Time-to-cure and cure proportion in solid cancers in France. A population based study.

V. Jooste, A. Bouvier, L. Remontet, 2019, Cancer epidemiology.

Multi‐dimensional penalized hazard model with continuous covariates: applications for studying trends and social inequalities in cancer survival

L. Tron, L. Remontet, N. Bossard, 2019, Journal of the Royal Statistical Society: Series C (Applied Statistics).

Description of an approach based on maximum likelihood to adjust an excess hazard model with a random effect.

L. Remontet, N. Bossard, A. Belot, 2013, Cancer epidemiology.

Trends in net survival from colon cancer in six European Latin countries: results from the SUDCAN population-based study

V. Jooste, J. Faivre, N. Bossard, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Seasonality of confirmed malaria cases from 2008 to 2017 in Togo: a time series analysis by health district and target group

N. Voirin, M. Rabilloud, N. Bossard, 2021, BMC Infectious Diseases.

Morphometric analysis of the distal femur in total knee arthroplasty and native knees.

M. Bonnin, J. Victor, N. Bossard, 2018, The bone & joint journal.

survPen: an R package for hazard and excess hazard modelling with multidimensional penalized splines

Laurent Remontet, Zoé Uhry, Mathieu Fauvernier, 2019, J. Open Source Softw..

Trends in net survival from kidney cancer in six European Latin countries: results from the SUDCAN population-based study

P. Giorgi Rossi, L. Mangone, R. Marcos-Gragera, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Is Pneumonectomy After Induction Chemotherapy for Non-small Cell Lung Cancer a Reasonable Procedure? A Multicenter Retrospective Study of 228 Cases

P. Souquet, L. Remontet, J. Baulieux, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study

S. Rosso, V. Zadnik, H. Brenner, 2019, Archives of Gynecology and Obstetrics.

Describing the association between socioeconomic inequalities and cancer survival: methodological guidelines and illustration with population-based data

B. Rachet, G. Launoy, A. Guizard, 2018, Clinical epidemiology.

Author's reply to: Estimating net survival in population‐based cancer studies

Coraline Danieli, L. Remontet, N. Bossard, 2013, International journal of cancer.

Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri.

Laurent Remontet, Jean Iwaz, Marc Colonna, 2011, Cancer epidemiology.

Éléments d’interprétation des estimations régionales de l’incidence du cancer en France sur la période 1980–2005

M. Colonna, P. Grosclaude, L. Remontet, 2008 .

Hazard regression model and cure rate model in colon cancer relative survival trends: are they telling the same story?

G. Launoy, V. Jooste, A. Bouvier, 2008, European Journal of Epidemiology.

[Some interpretation of regional estimates of the incidence of cancer in France over the period 1980--2005].

P. Grosclaude, L. Remontet, M. Colonna, 2008, Revue d'epidemiologie et de sante publique.

A Suitable Approach to Estimate Cancer Incidence in Area without Cancer Registry

L. Remontet, M. Colonna, N. Bossard, 2011, Journal of cancer epidemiology.

Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort

E. Leray, S. Vukusic, L. Remontet, 2021, Neurology.

Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial.

N. Girard, B. Chauffert, M. Ychou, 2010, International journal of radiation oncology, biology, physics.

Registry of Multicenter Clinical Trials: Twelfth and Thirteenth Report – 1990–1991

J. Boissel, N. Bossard, 1992, Thrombosis and Haemostasis.

Multidimensional penalized splines for incidence and mortality-trend analyses and validation of national cancer-incidence estimates.

G. Defossez, P. Grosclaude, L. Remontet, 2020, International journal of epidemiology.

Trends in net survival from esophageal cancer in six European Latin countries: results from the SUDCAN population-based study

C. Castro, G. Launoy, N. Bossard, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism.

F. Borson‐Chazot, P. Gaucherand, J. Orgiazzi, 2014, European journal of endocrinology.

Identifying Prevalent Cases of Breast Cancer in the French Case-mix Databases

M Colonna, A. Schott, L. Remontet, 2010, Methods of Information in Medicine.

Estimating net survival: the importance of allowing for informative censoring

Coraline Danieli, L. Remontet, N. Bossard, 2012, Statistics in medicine.

Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).

R. De Angelis, X. Troussard, M. Sant, 2015, The Lancet. Haematology.

Trends in net survival from stomach cancer in six European Latin countries: results from the SUDCAN population-based study

J. Faivre, A. Bouvier, N. Bossard, 2017, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Is Pneumonectomy After Induction Chemotherapy for Non-small Cell Lung Cancer a Reasonable Procedure? A Multicenter Retrospective Study of 228 Cases

P. Souquet, L. Remontet, J. Baulieux, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.